Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers decrease the incidence of atrial fibrillation: a meta-analysis. - Wikidata - awgldk - TriplyDB

Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers decrease the incidence of atrial fibrillation: a meta-analysis.

Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers decrease the incidence of atrial fibrillation: a meta-analysis.

http://www.wikidata.org/entity/Q33798432

about

Heart Disease and Stroke Statistics--2013 Update: A Report From the American Heart Association Angiotensin-converting enzyme inhibitors reduce mortality in hypertension: a meta-analysis of randomized clinical trials of renin-angiotensin-aldosterone system inhibitors involving 158,998 patients Safety of ACE inhibitor therapies in patients with chronic kidney disease.Oxidative stress in atrial fibrillation: an emerging role of NADPH oxidase.Induction of atrial fibrillation by neutrophils critically depends on CD11b/CD18 integrins.Role of the MAPKs/TGF-β1/TRAF6 signaling pathway in postoperative atrial fibrillation Prevention of atrial fibrillation with renin-angiotensin system inhibitors on essential hypertensive patients: a meta-analysis of randomized controlled trials.Risk Alteration for Atrial Fibrillation with DifferentAntihypertensive Drugs.Systematic review and meta-analysis: renin-Angiotensin system inhibitors in the prevention of atrial fibrillation recurrences: an unfulfilled hope.Atrial fibrillation in heart failure.Renin-angiotensin system inhibitors for prevention of recurrent atrial fibrillation: a meta-analysis.What do we actually know about the relationship between arterial hypertension and atrial fibrillation?Renin-angiotensin system blocking drugs.Enhanced cardioprotective effects mediated by plasmid containing the short-hairpin RNA of angiotensin converting enzyme with a biodegradable hydrogel after myocardial infarction.Influence of hospitalisation on the use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in elderly hypertensive patients.Supraventricular premature beats and risk of new-onset atrial fibrillation in coronary artery disease.Preventive effect of renin-angiotensin system inhibitors on new-onset atrial fibrillation in hypertensive patients: a propensity score matching analysis.Atrial fibrillation

P2860

Q22306356-5AFDCA3C-1463-4AA5-B30F-67C926BA8F8E Q27023161-EC38BC08-B24A-45F9-92BC-7C98E0F6C27C Q34434606-13557A9A-0E20-43D3-92D0-E164C25202B6 Q34651371-64B89D35-081D-4004-B7C5-4CFD2DB4B2D3 Q35099851-999DD27D-133B-4963-A689-830DB9480E2A Q36316380-8154BBC7-C0E3-4244-BE4A-5385C7C4E688 Q36325553-59063BB4-BD4C-4E28-8617-B606138C18E7 Q37495894-98162D2D-C8DD-43AD-91AB-332A53DF5316 Q37947093-B96C0318-3153-4CBA-9E8C-278C97C8A3B3 Q38032181-88497AF2-4A62-415F-AC14-63E6ACF8B217 Q38096077-0A3BA31D-E4D3-4909-9902-ECBB62DD725A Q38124318-2BDF05FB-ECA2-4744-A750-4EBA871D7E5B Q38137851-2FCAA440-3C49-4D63-817F-F41AF1F0A26D Q43415032-E104CFB9-D12F-44CE-83B7-32A01428C468 Q48304029-CDF7D4EF-38A9-45E6-9F74-5DDD237C8CB2 Q48344427-A00F5113-84F4-4A4D-8FC9-CD34C4A65048 Q53228943-57651A36-1FB5-4ED4-93AF-E0F1DEB876D3 Q56607936-98E92B1A-E1F8-4C52-B369-60540390C470

P2860

Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers decrease the incidence of atrial fibrillation: a meta-analysis.

http://www.wikidata.org/entity/Q33798432

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Angiotensin-converting enzyme ...... fibrillation: a meta-analysis.

@ast

Angiotensin-converting enzyme ...... fibrillation: a meta-analysis.

@en

type

label

Angiotensin-converting enzyme ...... fibrillation: a meta-analysis.

@ast

Angiotensin-converting enzyme ...... fibrillation: a meta-analysis.

@en

prefLabel

Angiotensin-converting enzyme ...... fibrillation: a meta-analysis.

@ast

Angiotensin-converting enzyme ...... fibrillation: a meta-analysis.

@en

P1433

Q33798432-AAB79993-9BEE-4115-8B79-B07670E14514

P1476

Q33798432-D9970330-2676-4D55-B6B8-AA1BF6C60107

P2093

Q33798432-09F41C18-6163-4FCC-A03F-380BB31CC1AD

Q33798432-0A642FBE-3396-4449-ACED-D794DF1B6850

Q33798432-119CEA5F-6501-475A-BE1D-EC750C140791

Q33798432-221E7461-9CEF-4971-9F97-F613EAE63E5C

Q33798432-23ED05FF-9CD3-4022-9C79-5B3AE9AD0F1C

Q33798432-67845FBF-9DF4-4B24-95EE-0AAFCE8C7873

Q33798432-76D06784-8479-49DE-94A0-5E929BE95845

Q33798432-80DE988C-DCCF-4187-9EBF-C6ABFB080015

Q33798432-B9317F60-42F6-48DB-A110-910EE7635B7D

Q33798432-CB2459F9-FF60-4827-BAC6-0D8ABE9E4CD3

P2860

Q33798432-05B68ECF-81E5-4A81-9E9F-11551B61391B

Q33798432-0A032518-5830-41FA-A4F8-6DFC00280FA2

Q33798432-13028E7A-C0F0-44D5-8041-81A590FE9FDE

Q33798432-255FED9E-14BF-49D6-B011-2E8646F71F0D

Q33798432-26276E10-AB25-4839-BBDA-393636B5DF0B

Q33798432-442A721F-D76F-43C0-BDB8-5D5E3A3D747F

Q33798432-4C80AD00-4954-49F6-98B5-98A8F9F8F636

Q33798432-55683BFD-F736-4183-B1CC-F234E760B1F9

Q33798432-61A5E352-9B44-4779-BB34-117B24F9CA09

Q33798432-735E88F5-EB20-4144-BE44-07AAA0860FD4

P304

Q33798432-302DCFE0-38DE-4DB5-837A-B0C5B9AA5707

P31

Q33798432-22d533a9-4bf0-4692-b1b5-916859abc22a

Q33798432-B67C863B-DB1D-4A14-881C-D52C71E744BA

P356

Q33798432-C5ABB662-0468-4865-B0C4-9270E4F575F9

P433

Q33798432-017AD5BB-0F10-49EB-9A81-74EC34F2BEB6

P478

Q33798432-A1C6ACEA-0E84-4EAE-AD7F-92F90EAFCB87

P577

Q33798432-279D42D8-B0D2-4B40-949C-65412445820E

P698

Q33798432-0CD02011-BE3A-46BF-BB71-E15EF7D2A7B7

P356

J.1365-2362.2010.02460.X

P1433

European Journal of Clinical Investigation

P1476

Angiotensin-converting enzyme ...... fibrillation: a meta-analysis.

@en

P2093

Akram Arkin

http://www.w3.org/2001/XMLSchema#string

Gang Huang

http://www.w3.org/2001/XMLSchema#string

Jian-xiong Liu

http://www.w3.org/2001/XMLSchema#string

Jun-bo Xu

http://www.w3.org/2001/XMLSchema#string

Mian Wang

http://www.w3.org/2001/XMLSchema#string

Qiu Li

http://www.w3.org/2001/XMLSchema#string

Si-qin Zhao

http://www.w3.org/2001/XMLSchema#string

Tao Wu

http://www.w3.org/2001/XMLSchema#string

Ting-jie Zhang

http://www.w3.org/2001/XMLSchema#string

Wen-yong Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

The appropriateness of asymmetry tests for publication bias in meta-analyses: a large survey

The case of the misleading funnel plot

Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

Atrial fibrillation as an independent risk factor for stroke: the Framingham Study

Incidence and prognostic significance of atrial fibrillation in acute myocardial infarction: the GISSI-3 data.

The role of angiotensin receptor blockers and/or angiotensin converting enzyme inhibitors in the prevention of atrial fibrillation in patients with cardiovascular diseases: meta-analysis of randomized controlled clinical trials.

Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial.

Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis.

P304

719-733

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1365-2362.2010.02460.X

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

41

http://www.w3.org/2001/XMLSchema#string

P577

2011-01-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21250983

http://www.w3.org/2001/XMLSchema#string